Ribomic Inc. (TYO:4591)

Ribomic Statistics

Total Valuation

Ribomic has a market cap or net worth of JPY 4.45 billion. The enterprise value is 1.23 billion.

Market Cap	4.45B
Enterprise Value	1.23B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Ribomic has 54.31 million shares outstanding. The number of shares has increased by 19.79% in one year.

Current Share Class	54.31M
Shares Outstanding	54.31M
Shares Change (YoY)	+19.79%
Shares Change (QoQ)	+2.98%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	10.14%
Float	51.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.38
P/TBV Ratio	1.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.17
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.19

Financial Position

The company has a current ratio of 25.36

Current Ratio	25.36
Quick Ratio	24.81
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.30% and return on invested capital (ROIC) is -7,546.38%.

Return on Equity (ROE)	-32.30%
Return on Assets (ROA)	-19.89%
Return on Invested Capital (ROIC)	-7,546.38%
Return on Capital Employed (ROCE)	-33.25%
Weighted Average Cost of Capital (WACC)	5.69%
Revenue Per Employee	n/a
Profits Per Employee	-42.12M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	133.60

Taxes

In the past 12 months, Ribomic has paid 1.00 million in taxes.

Income Tax	1.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.20% in the last 52 weeks. The beta is 0.26, so Ribomic's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-1.20%
50-Day Moving Average	81.12
200-Day Moving Average	93.03
Relative Strength Index (RSI)	43.58
Average Volume (20 Days)	800,115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-334.00M
Operating Income	-1.08B
Pretax Income	-1.05B
Net Income	-1.05B
EBITDA	-1.08B
EBIT	-1.08B
Earnings Per Share (EPS)	-23.78

Balance Sheet

The company has 3.22 billion in cash and n/a in debt, with a net cash position of 3.22 billion or 59.31 per share.

Cash & Cash Equivalents	3.22B
Total Debt	n/a
Net Cash	3.22B
Net Cash Per Share	59.31
Equity (Book Value)	3.24B
Book Value Per Share	63.01
Working Capital	3.19B

Cash Flow

In the last 12 months, operating cash flow was -1.02 billion and capital expenditures -10.00 million, giving a free cash flow of -1.03 billion.

Operating Cash Flow	-1.02B
Capital Expenditures	-10.00M
Free Cash Flow	-1.03B
FCF Per Share	-19.02

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ribomic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.79%
Shareholder Yield	-19.79%
Earnings Yield	-23.65%
FCF Yield	-23.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ribomic has an Altman Z-Score of 17.37 and a Piotroski F-Score of 1.

Altman Z-Score	17.37
Piotroski F-Score	1